Literature DB >> 34985657

A Reliable Primary Cell Model for HIV Latency: The QUECEL (Quiescent Effector Cell Latency) Method.

Meenakshi Shukla1, Fredrick Kizito1, Uri Mbonye1, Kien Nguyen1, Curtis Dobrowolski1,2, Jonathan Karn3.   

Abstract

One of the main methods to generate the HIV reservoir is during the transition of infected activated effector CD4 T cells to a memory phenotype. The QUECEL (Quiescent Effector Cell Latency) protocol mimics this process efficiently and allows for production of large numbers of latently infected CD4+ T cells. After polarization and expansion, CD4+ T cells are infected with a single round reporter virus which expressed GFP/CD8a. The infected cells are purified and coerced into quiescence using a defined cocktail of cytokines including TGF-β, IL-10, and IL-8, producing a homogeneous population of latently infected cells. Since homogeneous populations of latently infected cells can be recovered, the QUECEL model has an excellent signal-to-noise ratio, and has been extremely consistent and reproducible in numerous experiments performed during the last 5 years. The ease, efficiency, and accurate mimicking of physiological conditions make the QUECEL model a robust and reproducible tool to study the molecular mechanisms underlying HIV latency.
© 2022. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Cellular quiescence; Cytokines; HIV latency; Memory T-cells; QUECEL model

Mesh:

Substances:

Year:  2022        PMID: 34985657     DOI: 10.1007/978-1-0716-1871-4_5

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  27 in total

1.  Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy.

Authors:  D Finzi; J Blankson; J D Siliciano; J B Margolick; K Chadwick; T Pierson; K Smith; J Lisziewicz; F Lori; C Flexner; T C Quinn; R E Chaisson; E Rosenberg; B Walker; S Gange; J Gallant; R F Siliciano
Journal:  Nat Med       Date:  1999-05       Impact factor: 53.440

2.  Negative elongation factor is required for the maintenance of proviral latency but does not induce promoter-proximal pausing of RNA polymerase II on the HIV long terminal repeat.

Authors:  Julie K Jadlowsky; Julian Y Wong; Amy C Graham; Curtis Dobrowolski; Renee L Devor; Mark D Adams; Koh Fujinaga; Jonathan Karn
Journal:  Mol Cell Biol       Date:  2014-03-17       Impact factor: 4.272

3.  HIV reproducibly establishes a latent infection after acute infection of T cells in vitro.

Authors:  Albert Jordan; Dwayne Bisgrove; Eric Verdin
Journal:  EMBO J       Date:  2003-04-15       Impact factor: 11.598

4.  T-cell receptor signaling enhances transcriptional elongation from latent HIV proviruses by activating P-TEFb through an ERK-dependent pathway.

Authors:  Young Kyeung Kim; Uri Mbonye; Joseph Hokello; Jonathan Karn
Journal:  J Mol Biol       Date:  2011-07-29       Impact factor: 5.469

5.  Differences in HIV burden and immune activation within the gut of HIV-positive patients receiving suppressive antiretroviral therapy.

Authors:  Steven A Yukl; Sara Gianella; Elizabeth Sinclair; Lorrie Epling; Qingsheng Li; Lijie Duan; Alex L M Choi; Valerie Girling; Terence Ho; Peilin Li; Katsuya Fujimoto; Harry Lampiris; C Bradley Hare; Mark Pandori; Ashley T Haase; Huldrych F Günthard; Marek Fischer; Amandeep K Shergill; Kenneth McQuaid; Diane V Havlir; Joseph K Wong
Journal:  J Infect Dis       Date:  2010-10-12       Impact factor: 5.226

6.  NF-kappaB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation.

Authors:  Samuel A Williams; Lin-Feng Chen; Hakju Kwon; Carmen M Ruiz-Jarabo; Eric Verdin; Warner C Greene
Journal:  EMBO J       Date:  2005-12-01       Impact factor: 11.598

7.  Epigenetic silencing of human immunodeficiency virus (HIV) transcription by formation of restrictive chromatin structures at the viral long terminal repeat drives the progressive entry of HIV into latency.

Authors:  Richard Pearson; Young Kyeung Kim; Joseph Hokello; Kara Lassen; Julia Friedman; Mudit Tyagi; Jonathan Karn
Journal:  J Virol       Date:  2008-10-01       Impact factor: 5.103

8.  An in-depth comparison of latent HIV-1 reactivation in multiple cell model systems and resting CD4+ T cells from aviremic patients.

Authors:  Celsa A Spina; Jenny Anderson; Nancie M Archin; Alberto Bosque; Jonathan Chan; Marylinda Famiglietti; Warner C Greene; Angela Kashuba; Sharon R Lewin; David M Margolis; Matthew Mau; Debbie Ruelas; Suha Saleh; Kotaro Shirakawa; Robert F Siliciano; Akul Singhania; Paula C Soto; Valeri H Terry; Eric Verdin; Christopher Woelk; Stacey Wooden; Sifei Xing; Vicente Planelles
Journal:  PLoS Pathog       Date:  2013-12-26       Impact factor: 6.823

9.  Multiple Histone Lysine Methyltransferases Are Required for the Establishment and Maintenance of HIV-1 Latency.

Authors:  Kien Nguyen; Biswajit Das; Curtis Dobrowolski; Jonathan Karn
Journal:  mBio       Date:  2017-02-28       Impact factor: 7.867

10.  Differentiation into an Effector Memory Phenotype Potentiates HIV-1 Latency Reversal in CD4+ T Cells.

Authors:  Deanna A Kulpa; Aarthi Talla; Jessica H Brehm; Susan Pereira Ribeiro; Sally Yuan; Anne-Gaelle Bebin-Blackwell; Michael Miller; Richard Barnard; Steven G Deeks; Daria Hazuda; Nicolas Chomont; Rafick-Pierre Sékaly
Journal:  J Virol       Date:  2019-11-26       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.